Brian Henick, MD, discussed plans to investigate agents targeting ULBP2/5/6, antibody-drug conjugates, and other novel therapies in lung cancer research.
Brian Henick, MD
Advertisement
Articles by Brian Henick, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Daraxonrasib/Vopimetostat Yield Stunning Response Rate in MTAP-del Pancreatic Cancer
2
Melanoma Trials You May Have Missed at ASCO 2026
3
Radiation Oncology Trials You May Have Missed at ASCO 2026
4
Subcutaneous Isatuximab Earns EU Approval in Multiple Myeloma
5